Because the pre-existence of tumor-infiltrating CD8 T cells favors responses to anti-PD1 treatment46, we then examined the effect of dietary AhR ligands on the induction of antigen-specific CD8 T cell responses at baseline. The gene discussed is AHR; the disease is neoplasm.